Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia
- 6 January 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (1) , 28-33
- https://doi.org/10.1038/sj.leu.2401640
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human CancersThe American Journal of Pathology, 1999
- Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during developmentBioEssays, 1999
- Association of p27Kipl Levels With Recurrence and Survival in Patients With Stage C Prostate CarcinomaJNCI Journal of the National Cancer Institute, 1998
- Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteinsThe EMBO Journal, 1997
- Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylationLeukemia, 1997
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patientsNature Medicine, 1997
- Translational Control of p27 Kip1 Accumulation During the Cell CycleScience, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995